Epidemiology and survival outcome of breast cancer in a nationwide study

被引:61
作者
Liu, Fu-Chao [1 ,2 ]
Lin, Huan-Tang [1 ,2 ]
Kuo, Chang-Fu [3 ,4 ]
See, Lai-Chu [5 ,6 ]
Chiou, Meng-Jiun [7 ]
Yu, Huang-Ping [1 ,2 ]
机构
[1] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan
[4] Univ Nottingham, Div Rheumatol Orthopaed & Dermatol, Nottingham NG7 2RD, England
[5] Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan
[6] Chang Gung Univ, Mol Med Res Ctr, Biostat Core Lab, Taoyuan, Taiwan
[7] Chang Gung Mem Hosp, Off Big Data Res, Taoyuan, Taiwan
关键词
breast cancer; epidemiology; survival outcome; nationwide population study; SCREENING MAMMOGRAPHY; MOLECULAR SUBTYPES; HONG-KONG; RISK; VALIDATION; MORTALITY; RECURRENCE; SINGAPORE; DECISIONS; FEATURES;
D O I
10.18632/oncotarget.15207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is among the most prevalent cancers in Taiwan. The National Health Insurance database was used to identify patients with breast cancer and estimate the yearly prevalence and incidence of breast cancer between 1997 and 2013. Joinpoint regression analysis was used for the annual percentage change of incidence, prevalence, and survival outcome. Among 12,181,919 female beneficiaries in 2013, the prevalence was 834.37 per 100,000 persons (95% confidence interval, 829.28-839.45) and the incidence was 93.00 per 100,000 person-year (95% confidence interval, 91.27-94.73). The average annual percentage change of the age-standardized breast cancer incidence was 3.5 per 100,000 person-years (3.1-3.8; P < 0.05), suggesting an increase in breast cancer incidence over the study period. The 5-year mortality rate was 4.5% in 1997 and 4.4% in 2008. The 5-year mortality rate among patients with Charlson comorbidity index > 1 was 39.1% (19.2%-59.1%) in 1997 and 21.1% (15.7%-32.0%) in 2008, with an annual percentage change of -0.8 (-1.3 to 2.9), suggesting that the mortality rate was gradually decreasing in patients with comorbidities. In conclusion, 1 in 120 women in Taiwan has breast cancer and the incidence is rising, while the annual percentage change of breast cancer prevalence is decreasing. The mortality rate of breast cancer was essentially stable, but the 1-year, 2-year, and 5-year mortality rates in people with Charlson comorbidity index > 1 were declined.
引用
收藏
页码:16939 / 16950
页数:12
相关论文
共 35 条
[1]   Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy [J].
Arvold, Nils D. ;
Taghian, Alphonse G. ;
Niemierko, Andrzej ;
Raad, Rita F. Abi ;
Sreedhara, Meera ;
Nguyen, Paul L. ;
Bellon, Jennifer R. ;
Wong, Julia S. ;
Smith, Barbara L. ;
Harris, Jay R. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (29) :3885-3891
[2]   Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980-2013): an analysis of population-based data in relation to socioeconomic changes [J].
Banas, Tomasz ;
Juszczyk, Grzegorz ;
Pitynski, Kazimierz ;
Nieweglowska, Dorota ;
Ludwin, Artur ;
Czerw, Aleksandra .
ONCOTARGETS AND THERAPY, 2016, 9 :5521-5530
[3]   Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence [J].
Bleyer, Archie ;
Welch, H. Gilbert .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (21) :1998-2005
[4]   70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer [J].
Cardoso, F. ;
van't Veer, L. J. ;
Bogaerts, J. ;
Slaets, L. ;
Viale, G. ;
Delaloge, S. ;
Pierga, J. -Y. ;
Brain, E. ;
Causeret, S. ;
DeLorenzi, M. ;
Glas, A. M. ;
Golfinopoulos, V. ;
Goulioti, T. ;
Knox, S. ;
Matos, E. ;
Meulemans, B. ;
Neijenhuis, P. A. ;
Nitz, U. ;
Passalacqua, R. ;
Ravdin, P. ;
Rubio, I. T. ;
Saghatchian, M. ;
Smilde, T. J. ;
Sotiriou, C. ;
Stork, L. ;
Straehle, C. ;
Thomas, G. ;
Thompson, A. M. ;
van der Hoeven, J. M. ;
Vuylsteke, P. ;
Bernards, R. ;
Tryfonidis, K. ;
Rutgers, E. ;
Piccart, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08) :717-729
[5]   Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial [J].
Chan, Arlene ;
Delaloge, Suzette ;
Holmes, Frankie A. ;
Moy, Beverly ;
Iwata, Hiroji ;
Harvey, Vernon J. ;
Robert, Nicholas J. ;
Silovski, Tajana ;
Gokmen, Erhan ;
von Minckwitz, Gunter ;
Ejlertsen, Bent ;
Chia, Stephen K. L. ;
Mansi, Janine ;
Barrios, Carlos H. ;
Gnant, Michael ;
Buyse, Marc ;
Gore, Ira ;
Smith, John, II ;
Harker, Graydon ;
Masuda, Norikazu ;
Petrakova, Katarina ;
Guerrero Zotano, Angel ;
Iannotti, Nicholas ;
Rodriguez, Gladys ;
Tassone, Pierfrancesco ;
Wong, Alvin ;
Bryce, Richard ;
Ye, Yining ;
Yao, Bin ;
Martin, Miguel .
LANCET ONCOLOGY, 2016, 17 (03) :367-377
[6]   Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women [J].
Chay, Wen Yee ;
Ong, Whee Sze ;
Tan, Puay Hoon ;
Leo, Nicholas Qi Jie ;
Ho, Gay Hui ;
Wong, Chia Siong ;
Chia, Kee Seng ;
Chow, Khuan Yew ;
Tan, MinHan, Sr. ;
Ang, Peter, Sr. .
BREAST CANCER RESEARCH, 2012, 14 (01)
[7]   Cancer Trends in Taiwan [J].
Chiang, Chun-Ju ;
Chen, Yong-Chen ;
Chen, Chien-Jen ;
You, San-Lin ;
Lai, Mei-Shu .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (10) :897-904
[8]  
Chiang CJ, 2016, J FORMOS MED ASS
[9]   Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database Matched-Pair Analysis of Patients With Female Breast Cancer [J].
Choi, Min-Young ;
Lee, Se Kyung ;
Lee, Jeong Eon ;
Park, Hyung Seok ;
Lim, Seung Taek ;
Jung, Yongsik ;
Ko, Byung Kyun ;
Nam, Seok Jin .
MEDICINE, 2016, 95 (16)
[10]   Associations between Medical Conditions and Breast Cancer Risk in Asians: A Nationwide Population-Based Study in Taiwan [J].
Chuang, Shu-Chun ;
Wu, Guo-Jie ;
Lu, Yen-Shen ;
Lin, Ching-Hung ;
Hsiung, Chao Agnes .
PLOS ONE, 2015, 10 (11)